REVOLUTION Medicines

REVOLUTION Medicines(RVMDW)

REDWOOD CITY, CA
Biotechnology

Focus: Small Molecules

REVOLUTION Medicines is a life sciences company focused on Small Molecules.

OncologyNeurologyGastroenterologyRespiratory
Funding Stage
PUBLIC
Total Funding
$1B
Open Jobs
243

Pipeline & Clinical Trials

Clinical Trials (1)
NCT06040541Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Phase 1
RMC-4630
Solid Tumors
Phase 1
Clinical Trials (1)
NCT05462717Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Phase 1
RMC-5552
Solid Tumors
Phase 1
Clinical Trials (1)
NCT04774952Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1
RMC-5552
Glioblastoma
Phase 1
Clinical Trials (1)
NCT05557292RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
Phase 1
Clinical Trials (1)
NCT07349537Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Phase 1
TNG462
PDAC
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT07397338Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT06445062Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Phase 1/2
Clinical Trials (1)
NCT06128551Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT05379985Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 1/2
RMC-4630
Solid Tumor
Phase 1/2
Clinical Trials (1)
NCT06162221Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Phase 1/2
daraxonrasib
Pancreatic Cancer
Phase 3
Clinical Trials (1)
NCT07252232Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 3
Phase 3
Clinical Trials (1)
NCT06625320Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 3
Clinical Trials (1)
NCT06881784Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Phase 3

Open Jobs (243)

Associate Director, Commercial Supply Chain

Redwood City, California, United States
Manufacturing
1w ago
From $186K/yr

Senior Director, Clinical Data Management

Redwood City, California, United States
Quantitative Sciences
1w ago
From $244K/yr

Scientific Writer, Integrated Research Management

Redwood City, California, United States
Research & Development
1w ago
From $143K/yr

Senior Director, Biostatistics, Europe

Remote
Quantitative Sciences
1w ago

Intern, Computational Biology

Redwood City, California, United States
Quantitative Sciences
1w ago
From $67K/yr

Executive Director, AI/ML Drug Discovery Analytics

Redwood City, California, United States
Research & Development
1w ago
From $326K/yr

Intern Clinical Operations Execution Optimization

Redwood City, California, United States
Clinical Operations
1w ago
From $67K/yr

Director, Stakeholder Engagement Strategy & Operations

Remote
Medical Affairs
1w ago
From $201K/yr

Intern, Human Resources

Redwood City, California, United States
Human Resources
1w ago
From $67K/yr

Executive Director, Employment Law

Redwood City, California, United States
Legal
1w ago
From $311K/yr

Intern, Clinical Supply Chain

Redwood City, California, United States
Manufacturing
2w ago
From $67K/yr

Intern, Clinical Trial Operations, Clinical Operations

Redwood City, California, United States
Clinical Operations
2w ago
From $67K/yr

Intern, Computational Oncology

Redwood City, California, United States
Research & Development
2w ago
From $67K/yr

Intern, Clinical Supply Chain

Redwood City, California, United States
Clinical Operations
2w ago
From $67K/yr

Intern, Regulatory Affairs

Redwood City, California, United States
Regulatory Affairs
2w ago
From $67K/yr

Intern, External Data Coordinator

Redwood City, California, United States
Quantitative Sciences
2w ago
From $67K/yr

Intern, Competitive Intelligence

Redwood City, California, United States
Global Commercialization
2w ago
From $67K/yr

Intern, Bioinformatics

Redwood City, California, United States
Research & Development
2w ago
From $67K/yr

Director, Alliance Management

Redwood City, California, United States
Corporate Development
2w ago
From $211K/yr

US Commercial Field, Project Coordinator

Redwood City, California, United States
US Commercialization
2w ago
From $120K/yr

Director, Business Growth and Enablement

Redwood City, California, United States
Program Team Leadership
2w ago
From $211K/yr

Manager, Sample Management

Redwood City, California, United States
Research & Development
2w ago
From $143K/yr

Manager, Biospecimen Operations, Translational Medicine

Redwood City, California, United States
Quantitative Sciences
2w ago
From $143K/yr

Senior Manager, Clinical Supply Chain

Redwood City, California, United States
Manufacturing
2w ago
From $164K/yr

Senior Director, Pipeline & Product Communications

Redwood City, California, United States
Corporate Affairs
2w ago
From $244K/yr
View all 243 open positions →
Interview Prep Quick Facts
Founded: 2023
Portfolio: 15 clinical trials
Top TAs: Oncology
SEC Filings: 2 available
Open Roles: 243 active jobs
Therapeutic Area Focus
Oncology
14 pipeline
Marketed
Pipeline

Financials (FY2025)

Revenue
$12M67%
R&D Spend
$423M(3654%)67%
Net Income
-$436M
Cash
$696M

Hiring Trend

Stable
243
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles